Literature DB >> 7627091

Heat shock protein expression in oral epithelial dysplasia and squamous cell carcinoma.

P B Sugerman1, N W Savage, L J Xu, L J Walsh, G J Seymour.   

Abstract

Heat shock protein (HSP) expression is upregulated in tumour cells and, therefore, HSP expression is a likely marker of the malignant potential of oral epithelial lesions. Furthermore, the 70-kDa HSP (HSP 70) is implicated in the degree of tumour differentiation, the rate of tumour proliferation and the magnitude of the anti-tumour immune response. Accordingly, the distribution and intensity of HSP 70 expression was assessed in the epithelial compartment of oral squamous cell carcinoma (SCC, n = 29), dysplastic oral epithelium (n = 18) and benign oral mucosal lesions (n = 22) using avidin-biotin complex immunohistochemistry and microdensitometry under standardised conditions. Staining intensity was recorded in kilo-ohms (k omega). Normal oral mucosa (n = 15) was used for comparison, and results were analysed using Kruskall-Wallis and Fisher's exact tests. The distribution of HSP 70 expression in well differentiated SCC was significantly different from that in poorly differentiated SCC (P < 0.05), the latter demonstrating a more focal staining pattern. Median staining intensity in SCC (6.22 k omega), epithelial dysplasia (9.61 k omega) and the benign oral mucosal lesions (8.28 k omega) was significantly greater than that in normal oral mucosa (5.64 k omega; P < 0.05). Staining intensity in poorly differentiated SCC (7.66 k omega) was greater than that in moderately differentiated SCC (4.77 k omega), although this result just failed to reach statistical significance (P = 0.06). These results suggest that, as employed currently, HSP 70 expression is not a definitive marker of oral malignancy or malignant potential.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627091     DOI: 10.1016/0964-1955(94)00034-2

Source DB:  PubMed          Journal:  Eur J Cancer B Oral Oncol        ISSN: 0964-1955


  7 in total

1.  Salivary extracellular heat shock protein 70 (eHSP70) levels increase after 59 min of intense exercise and correlate with resting salivary secretory immunoglobulin A (SIgA) levels at rest.

Authors:  Yosuke Murase; Kazuhiro Shimizu; Yuko Tanimura; Yukichi Hanaoka; Koichi Watanabe; Ichiro Kono; Shumpei Miyakawa
Journal:  Cell Stress Chaperones       Date:  2015-11-25       Impact factor: 3.667

2.  Systemic and local effects of long-term exposure to alkaline drinking water in rats.

Authors:  M E Merne; K J Syrjänen; S M Syrjänen
Journal:  Int J Exp Pathol       Date:  2001-08       Impact factor: 1.925

3.  Overexpression of human 27 kDa heat shock protein in laryngeal cancer cells confers chemoresistance associated with cell growth delay.

Authors:  Jung-Hee Lee; Dongil Sun; Kwang-Jae Cho; Min-Sik Kim; Myung-Hwa Hong; In-Kyung Kim; Jae-Seon Lee; Jeong-Hwa Lee
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-12       Impact factor: 4.553

4.  Heat shock protein 70 (HSP70) expression is associated with poor prognosis in intestinal type gastric cancer.

Authors:  Hyoun Wook Lee; Eun Hee Lee; Seok-Hyun Kim; Mee Sook Roh; Sang Bong Jung; Young Cheol Choi
Journal:  Virchows Arch       Date:  2013-08-04       Impact factor: 4.064

5.  Prognostic significance of heat shock protein 70 (HSP70) in patients with oral cancer.

Authors:  Frank Tavassol; Oliver F Starke; Horst Kokemüller; Gerd Wegener; Corinna C M Müller-Tavassol; Nils-Claudius Gellrich; André Eckardt
Journal:  Head Neck Oncol       Date:  2011-02-23

6.  Heat shock protein (HSP70) as a marker of epithelial dysplasia in oral dysplastic lesions: A clinicopathological study.

Authors:  Preeti Patil; Kirty Nandimath; Sudeendra Prabhu; Venkatesh G Naikmasur
Journal:  J Oral Maxillofac Pathol       Date:  2015 Jan-Apr

7.  Prognosis and predictive value of heat-shock proteins expression in oral cancer: A PRISMA-compliant meta-analysis.

Authors:  Wei Lu; Yongwu Wang; Min Gan; Qingyun Duan
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.